Risperdal 1mg / 1ml Oral Solution
PDF Leaflet Revision Date: 2 June 2017
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of schizophrenia, mania in bipolar disorder, and disruptive behavior disorders in children.
Dosage (summary)
Adults: Start at 2 mg/day, increase to 4 mg/day on day 2; maintenance 4-8 mg/day. Elderly/renal impairment: Start at 0.5 mg twice daily.
Onset of Action / Duration
Onset: 1-2 hours, Duration: 24 hours for active metabolite.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use only if benefits outweigh risks; contraindicated in breastfeeding.
Key Drug Interactions
- Caution with alcohol and CNS depressants
- Antagonizes levodopa
- Increased mortality with furosemide
Contraindications
- Known sensitivity to components
- Children under 5 years
- Parkinsonu2019s disease
- Lewy Body Dementia
Common side effects
- Increased weight
- Tachycardia
- Parkinsonism
- Dizziness
- Somnolence
Counselling Points
- Monitor for weight gain
- Avoid dehydration
- Caution with driving or machinery
- Report signs of hyperglycemia
Serious warnings
- Increased mortality in elderly with dementia
- Cerebrovascular adverse events
- Neuroleptic Malignant Syndrome
Important Disclaimer
The Risperdal 1mg / 1ml Oral Solution professional information leaflet below is the property of Janssen and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
